General keynote: proteomic patterns in sera serve as biomarkers of ovarian cancer.

Lance A. Liotta; Emanuel F. Petricoin; Ali M. Ardekani; Ben A. Hitt; Peter J. Levine; Vincent A. Fusaro; Seth M. Steinberg; Gordon B. Mills; Charles Simone; David A. Fishman; Elise C. Kohn

doi:10.1006/gyno.2002.6679

General keynote: proteomic patterns in sera serve as biomarkers of ovarian cancer.

Lance A. Liotta^*, Emanuel F. Petricoin, Ali M. Ardekani, Ben A. Hitt, Peter J. Levine, Vincent A. Fusaro, Seth M. Steinberg, Gordon B. Mills, Charles Simone, David A. Fishman, Elise C. Kohn

^*Corresponding author for this work

Research output: Contribution to journal › Review article › peer-review

30 Scopus citations

Original language	English
Pages (from-to)	S25-28; discussion S37-2842
Journal	Gynecologic Oncology
Volume	88
Issue number	1 Pt 2
DOIs	https://doi.org/10.1006/gyno.2002.6679
State	Published - Jan 2003
Externally published	Yes

Access to Document

10.1006/gyno.2002.6679

Cite this

@article{da665c7c57554b3fb69c82b7ce65bd35,

title = "General keynote: proteomic patterns in sera serve as biomarkers of ovarian cancer.",

author = "Liotta, {Lance A.} and Petricoin, {Emanuel F.} and Ardekani, {Ali M.} and Hitt, {Ben A.} and Levine, {Peter J.} and Fusaro, {Vincent A.} and Steinberg, {Seth M.} and Mills, {Gordon B.} and Charles Simone and Fishman, {David A.} and Kohn, {Elise C.}",

note = "Funding Information: †FDA–NCI Clinical Proteomics Program, *Laboratory of Pathology and §Biostatistics and Data Management Section, CCR, National Cancer Institute, National Institutes of Health; ‡Correlogic Systems, Inc.; ¶M.D. Anderson Cancer Center; ‖Simone Protective Cancer Institute; and **Northwestern University Medical School",

year = "2003",

month = jan,

doi = "10.1006/gyno.2002.6679",

language = "English",

volume = "88",

pages = "S25--28; discussion S37--2842",

journal = "Gynecologic Oncology",

issn = "0090-8258",

publisher = "Academic Press Inc.",

number = "1 Pt 2",

}

TY - JOUR

T1 - General keynote

T2 - proteomic patterns in sera serve as biomarkers of ovarian cancer.

AU - Liotta, Lance A.

AU - Petricoin, Emanuel F.

AU - Ardekani, Ali M.

AU - Hitt, Ben A.

AU - Levine, Peter J.

AU - Fusaro, Vincent A.

AU - Steinberg, Seth M.

AU - Mills, Gordon B.

AU - Simone, Charles

AU - Fishman, David A.

AU - Kohn, Elise C.

N1 - Funding Information: †FDA–NCI Clinical Proteomics Program, *Laboratory of Pathology and §Biostatistics and Data Management Section, CCR, National Cancer Institute, National Institutes of Health; ‡Correlogic Systems, Inc.; ¶M.D. Anderson Cancer Center; ‖Simone Protective Cancer Institute; and **Northwestern University Medical School

PY - 2003/1

Y1 - 2003/1

UR - http://www.scopus.com/inward/record.url?scp=0037270358&partnerID=8YFLogxK

U2 - 10.1006/gyno.2002.6679

DO - 10.1006/gyno.2002.6679

M3 - Review article

C2 - 12586081

AN - SCOPUS:0037270358

SN - 0090-8258

VL - 88

SP - S25-28; discussion S37-2842

JO - Gynecologic Oncology

JF - Gynecologic Oncology

IS - 1 Pt 2

ER -

General keynote: proteomic patterns in sera serve as biomarkers of ovarian cancer.

Access to Document

Fingerprint

Cite this